Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
lactobacillus bulgaricus + streptococcus thermophilus + bifidobacterium lactis + lactobacillus acidophilus + lactobacillus plantarum ST-III
- Development stage
- Preclinical
- Lead developer
- Bright Dairy
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
This multi-strain probiotic combination consists of *Lactobacillus bulgaricus*, *Streptococcus thermophilus*, *Bifidobacterium lactis*, *Lactobacillus acidophilus*, and the specific patented strain *Lactobacillus plantarum* ST-III. Developed primarily by Bright Dairy & Food, this blend is designed to survive gastric transit due to the high acid and bile tolerance of the ST-III strain. The microorganisms work synergistically to modulate the gut microbiota, inhibit the growth of pathogenic bacteria through competitive exclusion and the production of organic acids, and enhance the integrity of the intestinal mucosal barrier. It is commonly utilized in dietary supplements and functional foods to improve digestive health, alleviate constipation, and support immune function.
- Brand names
- Bright ProbioticProbio-STIII
- Other names
- 5-strain probiotic blendBright Dairy Probiotic Formulation
Beyond the preview
Go deeper on lactobacillus bulgaricus + streptococcus thermophilus + bifidobacterium lactis + lactobacillus acidophilus + lactobacillus plantarum ST-III.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on lactobacillus bulgaricus + streptococcus thermophilus + bifidobacterium lactis + lactobacillus acidophilus + lactobacillus plantarum ST-III.